The role of inflammation in progression of breast cancer: Friend or foe?

被引：54

作者：

Allen, Michael D. ^{[1
]}

Jones, Louise J. ^{[1
]}

机构：

[1] Queen Mary Univ London, John Vane Sci Ctr, Canc Res UK Ctr Excellence, Ctr Tumour Biol,Barts Canc Inst, London EC1M 6BQ, England

来源：

INTERNATIONAL JOURNAL OF ONCOLOGY | 2015年 / 47卷 / 03期

关键词：

breast cancer; ductal carcinoma in situ; inflammation; progression; CARCINOMA IN-SITU; TUMOR-INFILTRATING LYMPHOCYTES; MONOCYTE CHEMOTACTIC PROTEIN-1; REGULATORY T-CELLS; MACROPHAGE INFILTRATION; CHEMOATTRACTANT PROTEIN-1; MAMMARY CARCINOMAS; LOCAL RECURRENCE; FOXP3; EXPRESSION; MOUSE MODEL;

D O I：

10.3892/ijo.2015.3075

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

There is a growing interest in the role of the microenvironment in cancer, however, it has been known for over one hundred years that the immune system plays a prominent role in cancer. Recent decades have revealed more and more data on how our own host response to cancer cells can help or hinder progression of the disease. Despite all this work it is surprising how little is known about the role of the immune system in human breast cancer development, as compared to other cancers. Recent successes of PD-1 blockade in treating multiple cancers, and new developments with other immune targets such as CTLA-4 and CSF-1 inhibitors, highlight that it is becoming ever more important that we understand the complexity of the immune and inflammatory systems in the development and progression of breast cancer. With this knowledge it may be possible to not only target therapy but also more accurately predict those patients that truly need it. This review summarises some of the most significant findings for the role of the immune system and inflammatory response in breast cancer progression. Focusing on how the inflammatory microenvironment may be involved in the progression of pre-invasive ductal carcinoma in situ to invasive breast cancer. It will also discuss the use of immune markers as diagnostic and prognostic tools and summarise the state of the art of immune-therapeutics in breast cancer treatment.

引用

页码：797 / 805

页数：9

共 92 条

[11] Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer [J].

Brahmer, Julie R. ;

Tykodi, Scott S. ;

Chow, Laura Q. M. ;

Hwu, Wen-Jen ;

Topalian, Suzanne L. ;

Hwu, Patrick ;

Drake, Charles G. ;

Camacho, Luis H. ;

Kauh, John ;

Odunsi, Kunle ;

Pitot, Henry C. ;

Hamid, Omid ;

Bhatia, Shailender ;

Martins, Renato ;

Eaton, Keith ;

Chen, Shuming ;

Salay, Theresa M. ;

Alaparthy, Suresh ;

Grosso, Joseph F. ;

Korman, Alan J. ;

Parker, Susan M. ;

Agrawal, Shruti ;

Goldberg, Stacie M. ;

Pardoll, Drew M. ;

Gupta, Ashok ;

Wigginton, Jon M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2012, 366 (26) :2455-2465

[12] Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma [J].

Castro, Nadia P. ;

Osorio, Cynthia A. B. T. ;

Torres, Cesar ;

Bastos, Elen P. ;

Mourao-Neto, Mario ;

Soares, Fernando A. ;

Brentani, Helena P. ;

Carraro, Dirce M. .

BREAST CANCER RESEARCH, 2008, 10 (05)

[13] Oestrogen receptor negative breast cancers exhibit high cytokine content [J].

Chavey, Carine ;

Bibeau, Frederic ;

Gourgou-Bourgade, Sophie ;

Burlinchon, Sandrine ;

Boissiere, Florence ;

Laune, Daniel ;

Roques, Sylvie ;

Lazennec, Gwendal .

BREAST CANCER RESEARCH, 2007, 9 (01)

[14]

CHIN Y, 1992, ANTICANCER RES, V12, P1463

[15] Leukocytes in Mammary Development and Cancer [J].

Coussens, Lisa M. ;

Pollard, Jeffrey W. .

COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY, 2011, 3 (03) :1-22

[16] Immunotherapeutics for breast cancer [J].

Criscitiello, Carmen ;

Curigliano, Giuseppe .

CURRENT OPINION IN ONCOLOGY, 2013, 25 (06) :602-608

[17] Leukocyte Complexity Predicts Breast Cancer Survival and Functionally Regulates Response to Chemotherapy [J].

DeNardo, David G. ;

Brennan, Donal J. ;

Rexhepaj, Elton ;

Ruffell, Brian ;

Shiao, Stephen L. ;

Madden, Stephen F. ;

Gallagher, William M. ;

Wadhwani, Nikhil ;

Keil, Scott D. ;

Junaid, Sharfaa A. ;

Rugo, Hope S. ;

Hwang, E. Shelley ;

Jirstroem, Karin ;

West, Brian L. ;

Coussens, Lisa M. .

CANCER DISCOVERY, 2011, 1 (01) :54-67

[18] CD4+ T Cells Regulate Pulmonary Metastasis of Mammary Carcinomas by Enhancing Protumor Properties of Macrophages [J].

DeNardo, David G. ;

Barreto, Jairo B. ;

Andreu, Pauline ;

Vasquez, Lesley ;

Tawfik, David ;

Kolhatkar, Nikita ;

Coussens, Lisa M. .

CANCER CELL, 2009, 16 (02) :91-102

[19] Increased circulating myeloid-derived suppressor cells correlate with clinical cancer stage, metastatic tumor burden, and doxorubicin-cyclophosphamide chemotherapy [J].

Diaz-Montero, C. Marcela ;

Salem, Mohamed Labib ;

Nishimura, Michael I. ;

Garrett-Mayer, Elizabeth ;

Cole, David J. ;

Montero, Alberto J. .

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2009, 58 (01) :49-59

[20] Monocyte chemotactic protein-1 secreted by primary breast tumors stimulates migration of mesenchymal stem cells [J].

Dwyer, R. M. ;

Potter-Beirne, S. M. ;

Harrington, K. A. ;

Lowery, A. J. ;

Hennessy, E. ;

Murphy, J. M. ;

Barry, F. P. ;

O'Brien, T. ;

Kerin, M. J. .

CLINICAL CANCER RESEARCH, 2007, 13 (17) :5020-5027

← 1 2 3 4 5 6 7 8 9 10 →